Using sEMG of the Diaphragm to Assess Readiness for Extubation
2 other identifiers
observational
30
1 country
1
Brief Summary
As part of an admission to an Intensive Care Unit (ICU) many patients have breathing tube inserted into their windpipe, also referred to as intubation . This is done for a variety of reasons which can include the need for invasive breathing support and to place the patient into a medically induced coma to allow their body to rest and be treated for the underlying cause of their deterioration. One the patient has started to recover from their illness, the process of removing the breathing tube (extubation) and stopping the breathing machine begins. Optimising this process and ensuring successful removal of the breathing tube is extremely important to optimise outcomes. Therefore, identifying new methods to determine the likelihood for successful extubation is of clinical significance. There are several markers of extubation readiness that clinicians can use to support their decision making discussed in the literature. A novel method is the use of respiratory muscle activity monitoring via sensory electromyogram (sEMG). sEMG has previously been shown to be useful to measure the strength and activity of muscles. However, until recently measuring diaphragm activity has been a challenge due to noise from the chest movements, cardiac artefacts. Recent advancements in signal processing and growing interest in better diagnostic methods has led to an improvement in metrics. Using wavelet transforms and machine learning, new techniques have been developed to measure diaphragm muscle activity using sEMG. sEMG has been shown to be effective in detecting patient-ventilator asynchrony as well as respiratory strength in those not requiring mechanical ventilation. However, its use in assessing patients nearing readiness for extubation has not been explored. Therefore, the purpose of this feasibility trial is to explore the use of sEMG in patients undergoing trials of extubation. The results of this study will be used to design a multi-site trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedStudy Start
First participant enrolled
August 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedAugust 21, 2025
July 1, 2025
5 months
July 31, 2025
August 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of recruitment and retention of participants
To determine study feasibility by recruitment and retention rates from study participants across a single site
1 year
Secondary Outcomes (1)
Appropriateness of use of EMG for diaphragm strength
1 year
Study Arms (1)
Critical care cohort
Critical care cohort - all to have EMG completed. No other intervention
Eligibility Criteria
Patients admitted to critical care for level 3 support
You may qualify if:
- Patients requiring mechanical ventilation for \>72 hours
- Patients who an attempt at extubation is planned
- Patients who are willing or able to give informed consent (Where consultee advice is sought, informed consent from the participant will be completed as soon as possible).
You may not qualify if:
- Aged under 18 years
- Patients admitted with traumatic or spontaneous brain injury
- Patients for who extubation is planned as a palliative process
- Contra-indication to using sEMG e.g., permanent or temporary pacemaker, internal or external cardiac defibrillator, skin lesions around site of electrode placement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiff and Vale University Health Board
Cardiff, CF144XW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 7, 2025
Study Start
August 31, 2025
Primary Completion
January 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
August 21, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share